Connect with us


Researchers develop tuberculosis vaccine



Researchers develop tuberculosis vaccine

A group of researchers from around the world have joined forces to develop a vaccine which could revolutionise the treatment of tuberculosis.

The researchers claimed the vaccine would provide long-term protection against the disease, which kills 1.5 million people around the world each year.

At a global summit on lung health in the southern Indian city of Hyderabad on Tuesday, the researchers revealed that the vaccine, made up of proteins from bacteria can trigger an immune response.

David Lewinsohn, a TB expert, told the BBC the potential vaccine was a “real game changer.”

READ ALSO: Australian regulators sue Google over misuse of personal data

“What is really remarkable is that it was effective in adults who were already infected with Mycobacterium tuberculosis that is the causative agent of TB,” he said.

“As most people who are infected with Mycobacteriumtuberculosis do not get TB, we have believed that infection confers some degree of protection. As a result it is really exciting that a vaccine has been shown to improve on this natural immunity.”

Dr. Lewinsohn said the new vaccine had cleared a key “mid-phase development and it is designed to test both safety and provide an early indicator of efficacy.”

“It is likely that the vaccine will need to be tested in additional populations, and possibly bigger trials before it will be licensed. Assuming the data holds up in the remaining trials, which seems likely, this vaccine has the potential to revolutionise TB treatment,” he added.

Join the conversation


Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now